INSIDER · CIK 2081359
Lerner Lorena Raquel
Chief Scientific Officer at Keros Therapeutics, Inc. (KROS)
↗1 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$37KSold on the market
1Companies
Aug 20, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 20, 202616:10 | Aug 18, 2026 | KROSKeros Therapeutics, Inc. | Chief Scientific Officer | S · Sell | $10.29 | −3,568 | 27,559 | -11% | −$37K |